Cipher Pharmaceuticals(CPHRF)
$9.63+0.02 (+0.22%)
CPHRF
Cipher Pharmaceuticals financials statements
$9.63
At close:+0.02 (+0.22%)
Cipher Pharmaceuticals (CPHRF) Income Statement
21 Followers
Cipher Pharmaceuticals Income Statement
Last quarter (Q2 2026), Cipher Pharmaceuticals's total revenue was $11.76M, a decrease of 12.15% from the same quarter last year. In Q2, Cipher Pharmaceuticals's net income was $3.91M. See Cipher Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 51.33M | $ 33.36M | $ 21.16M | $ 20.68M | $ 21.94M | |
| $ 33.77M | $ 24.10M | $ 17.09M | $ 16.68M | $ 18.26M | |
| $ 16.97M | $ 16.25M | $ 5.56M | $ 5.63M | $ 6.45M | |
| Depreciation and Amortization | $ 7.23M | $ 4.02M | $ 1.23M | $ 989.00K | $ 701.00K |
| $ 24.10M | $ 11.87M | $ 11.53M | $ 12.04M | $ 13.66M | |
| $ 16.80M | $ 7.85M | $ 11.53M | $ 12.04M | $ 11.82M | |
| $ 661.38K | $ -4.89M | $ 1.15M | $ -560.00K | $ -2.00M | |
| $ 17.46M | $ 2.96M | $ 12.68M | $ 11.48M | $ 11.06M | |
| $ 27.81M | $ 11.54M | $ 20.38M | $ 26.64M | $ 7.76M | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.09 | $ 0.47 | $ 0.80 | $ 1.06 | $ 0.29 |
| Diluted EPS | $ 1.07 | $ 0.47 | $ 0.80 | $ 1.04 | $ 0.29 |
| Weighted Average Shares Outstanding | 25.48M | 24.57M | 25.42M | 25.13M | 26.60M |
| Weighted Average Shares Outstanding (Diluted) | 25.99M | 24.57M | 25.42M | 25.59M | 26.83M |
Currency in USD
